You raise interesting points.
Oposura sale would be an injection of funds at the right time.
So would AZS management go for a certain sale of Oposura or go for presales, so they can hedge on Alacran outcomes?
An outright sale would free up AZS from the bind of not having enough money for further exploration except from CRs or JVs. Hmm!
Ann: Quarterly Activities Report March 2019, page-36
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)